influenza
virus
caus
annual
epidem
occasion
global
pandem
viral
envelop
glycoprotein
ha
hemagglutinin
function
bind
cellular
receptor
mediat
fusion
endosom
membran
regard
mani
virus
public
health
concern
viral
envelop
protein
glycosyl
high
mannos
hm
glycan
instanc
hiv
envelop
mediat
direct
bind
receptor
highli
glycosyl
hm
glycan
high
level
hm
glycan
present
viral
surfac
glycoprotein
hcv
sarscov
influenza
viru
hm
glycan
abund
viral
ha
reportedli
present
near
receptor
bind
region
subunit
accordingli
hm
glycan
viral
surfac
attract
target
carbohydratebas
antivir
reagent
recent
discov
hmbind
lectin
famili
lower
organ
bacteria
cyanobacteria
marin
alga
repres
novel
class
antivir
compound
famili
includ
cyanobacteri
lectin
oaa
oscillatoria
agardhii
homolog
protein
bacteri
lectin
pfl
pseudomona
fluorescen
boa
burkholderia
oklahomensi
red
algal
lectin
eucheuma
serra
kappaphycu
alvarezii
commonli
two
four
tandem
repeat
consist
highli
conserv
sequenc
lack
homolog
exist
protein
famili
famili
protein
show
uniqu
topolog
lectin
includ
oaa
report
exhibit
strong
antihiv
activ
inhibit
initi
step
viru
entri
host
cell
low
nanomolar
rang
directli
bind
structur
insight
lectincarbohydr
interact
famili
molecular
basi
antihiv
properti
investig
exampl
structur
ligandbound
form
antihiv
lectin
boa
reveal
hydrogen
bond
associ
core
trisaccharid
compris
man
part
arm
carbohydr
bind
specif
protein
famili
evalu
centrifug
ultrafiltr
method
use
fluorescentlabel
oligosaccharid
aqueou
phase
glycan
array
analysi
solid
phase
analys
support
observ
xray
structur
trimannosyl
unit
primari
recognit
center
addit
nonreduc
termin
trisaccharid
disrupt
interact
lectin
oligosaccharid
lectin
famili
thu
independ
known
hmbind
antihiv
lectin
cyanovirinn
cvn
nostoc
ellipsosporum
grft
griffithsia
sp
term
molecular
structur
carbohydr
specif
cvn
extens
character
cyanobacteri
lectin
recogn
termini
hmglycan
show
wide
rang
antivir
activ
hiv
ebola
hcv
well
influenza
virus
red
algal
grft
bind
even
monosaccharid
well
hmglycan
display
broad
spectrum
inhibitori
activ
without
alter
gene
express
cytokin
product
besid
strong
antihiv
activ
found
oaa
lectin
famili
potent
antiinfluenza
viru
activ
also
demonstr
pfl
howev
red
algal
lectin
studi
inhibitori
effect
influenza
viru
infect
present
studi
examin
antiinfluenza
potenc
compar
variou
lectin
divers
carbohydratebind
specif
furthermor
molecular
basi
antiinfluenza
activ
also
evalu
aspect
lectinenvelop
glycoprotein
interact
novel
influenza
viru
subtyp
emerg
caus
pandem
world
lectin
sensit
profil
swine
origin
influenza
viru
examin
util
twelv
lectin
variou
carbohydratebind
specif
test
employ
neutral
red
nr
dye
uptak
assay
use
clinic
isol
viru
among
lectin
test
high
mannos
hm
bind
red
algal
lectin
eucheuma
serra
show
highest
potenc
inhibit
influenza
viru
infect
show
nm
figur
lectin
specif
recogn
branch
structur
hm
nglycan
includ
trisaccharid
compris
man
arm
primari
target
devoid
monosaccharid
bind
includ
mannos
well
nglycan
complex
type
hybrid
type
therefor
like
certain
hm
glycan
present
region
viru
surfac
involv
receptor
bind
critic
posit
viru
infect
would
specif
target
fact
site
specif
occurr
hm
glycan
subunit
report
previous
demonstr
four
bind
site
molecul
built
four
tandem
repeat
characterist
homolog
sequenc
lectin
famili
anoth
bacteri
lectin
famili
pfl
pseudomona
fluorescen
two
carbohydr
bind
site
carbohydr
specif
shown
exhibit
less
antiinfluenza
activ
compar
impli
higher
valenc
lectin
would
import
effect
captur
viru
particl
similarli
oblig
dimer
construct
cvn
show
enhanc
inhibit
fusion
compar
wild
type
cvn
monom
likewis
oligomer
state
grft
affect
hiv
inhibitori
potenc
grft
monomer
variant
grft
fail
inhibit
hiv
infect
shown
figur
dglcnacbind
lectin
includ
uda
urtica
dioica
wga
triticum
vulgari
exhibit
weak
antivir
activ
one
two
order
less
magnitud
comparison
human
influenza
virus
preferenti
recogn
link
sialic
acid
moieti
epitheli
cell
human
trachea
wherea
avian
influenza
virus
prefer
moieti
present
cell
intestin
tract
waterfowl
one
sialic
acidbind
lectin
mam
maackia
amurensi
preferenti
recogn
linkag
show
weak
activ
possibl
due
blockad
cell
surfac
receptor
rather
direct
bind
viru
particl
contrast
link
sialic
acidbind
lectin
sna
sambucu
nigra
fail
protect
cell
viru
infect
inhibit
profil
sialic
acidbind
lectin
strain
remain
controversi
deem
virtual
inact
inhibit
influenza
infect
hmbind
legum
lectin
cona
show
moder
antivir
activ
nm
fucosebind
lectin
aol
aspergillu
oryza
aal
aleuria
aurantia
also
inhibitori
nm
inhibitori
activ
fucosebind
lectin
much
weaker
compar
report
sitespecif
glycosyl
ha
mammalian
cell
depend
variou
factor
amino
acid
sequenc
ha
access
glycosyl
transferas
conform
posit
glycosyl
site
ha
structur
widespread
occurr
reduc
termin
fucos
residu
varieti
glycosyl
site
subunit
may
account
antivir
activ
fucosebind
lectin
report
influenza
virus
bound
fucosebranch
glycan
receptor
much
stronger
linear
glycan
therefor
might
also
possibl
fucosebind
lectin
exert
antiinfluenza
activ
block
fucosecontain
cell
receptor
explor
antivir
activ
nr
dye
uptak
assay
perform
variou
influenza
viru
strain
shown
figur
strongli
inhibit
infect
caus
influenza
viru
strain
except
earlier
laboratoryadapt
strain
lack
cvn
bind
resist
cvn
observ
strain
account
absenc
hm
glycan
near
cellular
bind
region
antivir
profil
similar
red
algal
lectin
kappaphycu
alvarezii
belong
antihiv
lectin
famili
show
broad
spectrum
antiinfluenza
viru
activ
low
nanomolar
rang
tabl
cytotox
observ
nm
highest
dose
experi
contrast
antivir
activ
fucosebind
aol
vari
significantli
depend
viru
strain
tabl
besid
insensit
aol
contrast
highli
suscept
aol
examin
whether
inhibit
viru
entri
cell
cellular
distribut
viral
antigen
either
presenc
absenc
observ
immunofluoresc
microscopi
presenc
nm
viral
antigen
detect
mdck
cell
infect
figur
addit
cytopath
effect
cpe
infect
cell
observ
contrast
mm
amantadin
channel
blocker
entri
inhibitor
influenza
viru
fail
block
viral
infect
host
cell
test
whether
inhibit
initi
viru
entri
anoth
earli
step
viral
replic
effect
determin
postinfect
data
figur
clearli
show
fail
inhibit
infect
administ
cell
h
postinfect
contrast
effect
inhibit
viru
replic
ad
cell
simultan
viru
result
indic
act
entri
inhibitor
direct
interact
influenza
envelop
ha
glycoprotein
demonstr
elisa
assay
figur
ha
dosedepend
bound
immobil
plate
refer
glycoprotein
interact
competit
inhibit
yeast
mannan
select
inhibitor
indic
bound
ha
hm
glycan
demonstr
cvn
exhibit
antiinfluenza
activ
directli
bind
antiinfluenza
activ
exemplifi
studi
seem
mechan
cvn
howev
despit
partial
overlap
carbohydr
specif
hmglycan
cvn
hmbind
lectin
mvl
microcysti
viridi
gna
galanthu
nivali
inhibit
hcv
infect
differ
complex
mode
action
respect
interact
cellular
protein
potenti
lead
variou
cellular
respons
prolifer
inflamm
taken
account
undertak
vivo
applic
evalu
effect
condit
model
natur
environ
perform
vitro
infect
assay
presenc
mucin
human
saliva
test
cell
infect
h
cell
viabil
determin
shown
figur
nm
effici
inhibit
viral
infect
presenc
mucin
type
bovin
submaxillari
gland
mucin
type
iii
porcin
stomach
human
saliva
although
saliva
inhibit
viral
infect
moder
studi
provid
first
evid
red
algal
lectin
potent
inhibit
influenza
viru
propag
directli
bind
hm
glycan
envelop
glycoprotein
ha
therefor
would
use
novel
entri
inhibitor
variou
virus
hm
glycan
prevent
transmiss
effect
assum
would
use
disinfect
prophylact
agent
eg
applic
spray
reagent
mask
etc
precis
investig
safeti
effect
could
develop
topic
microbicid
prevent
viru
infect
futur
work
direct
show
effect
use
anim
model
follow
lectin
purchas
seikagaku
corpor
tokyo
japan
aal
aleuria
aurantia
cona
canavalia
ensiformi
mam
maackia
amurensi
pna
arachi
hypogaea
pwm
phytolacca
americana
sba
glycin
max
wga
triticum
vulgari
follow
lectin
purchas
cosmo
bio
tokyo
japan
gna
galanthu
nivali
sna
sambucu
nigra
uda
urtica
dioica
lectin
aol
aspergillu
oryza
obtain
tokyo
chemic
industri
tokyo
japan
eucheuma
serra
prepar
describ
previous
kept
use
influenza
viru
vaccin
mixtur
purchas
denkaseiken
tokyo
japan
follow
virus
stock
one
author
examin
clinic
isol
recent
emerg
strain
also
examin
virus
propag
embryon
egg
aliquot
viru
prepar
use
assay
madindarbi
canin
kidney
mdck
cell
human
lung
carcinoma
cell
grown
host
cell
infect
studi
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
penicillinstreptomycin
antiinfluenza
activ
lectin
determin
neutral
red
nr
dye
uptak
assay
describ
previous
variou
concentr
lectin
prepar
dmem
contain
trypsin
ad
mdck
cell
cultur
micropl
subsequ
influenza
viru
inocul
well
multipl
infect
approxim
cell
incub
h
nr
dye
ad
incorpor
surviv
cell
incub
cell
formaldehyd
contain
incorpor
dye
elut
cell
acet
ethanol
color
intens
well
measur
nm
micropl
reader
multilabel
counter
perkinelm
waltham
usa
altern
infect
cell
fix
aceton
stain
amid
black
solut
amid
black
ethanol
acet
acid
stain
cell
well
pictur
greyscal
color
intens
quantit
imag
process
program
nih
imag
test
inhibitori
profil
nr
dye
uptak
assay
perform
describ
use
nine
influenza
viru
strain
one
influenza
b
viru
strain
comparison
antiinfluenza
viru
profil
fucosebind
lectin
aol
also
evalu
way
vitro
infect
assay
presenc
mucin
human
saliva
peform
follow
cell
infect
h
presenc
nm
dmem
contain
mucin
type
bovin
submaxillari
gland
mucin
type
iii
porcin
stomach
human
saliva
dilut
cell
viabil
evalu
amid
black
stain
describ
assess
whether
inhibit
initi
step
viral
infect
immunofluoresc
stain
perform
visual
viru
antigen
host
cell
briefli
mdck
cell
grown
cover
slip
infect
multipl
infect
approxim
presenc
nm
dmem
contain
trypsin
cell
fix
aceton
viru
antigen
detect
incub
mous
monoclon
antiha
antibodi
hytest
turku
finland
follow
fluorescein
isothiocyan
fitc
conjug
goat
antimous
igg
antibodi
anticorp
secondair
franc
cell
mount
vectashield
dapi
vector
laboratori
burlingam
ca
usa
observ
fluorescencemicroscop
olympu
olympu
tokyo
japan
enzymelink
immunosorb
assay
elisa
perform
examin
direct
interact
ha
influenza
viru
immobil
elisa
plate
bd
bioscienc
bedford
usa
describ
previous
well
block
skim
milk
subsequ
incub
influenza
vaccin
prepar
astella
tokyo
japan
contain
three
differ
influenza
subtyp
well
incub
mous
antiha
monoclon
antibodi
hytest
follow
incub
horseradish
peroxidas
hrp
conjug
goat
antimous
igg
antibodi
ge
healthcar
buckinghamshir
uk
detect
interact
tmb
substrat
hrp
sigmaaldrich
saintloui
mo
usa
ad
well
absorb
nm
measur
use
micropl
reader
multilabel
counter
inhibit
studi
mannan
yeast
ad
coat
plate
prior
incub
ha
vaccin
prepar
conclus
red
algal
lectin
e
serra
exert
antiinfluenza
activ
strongli
inhibit
cell
entri
variou
influenza
virus
strain
independ
manner
directli
bind
hm
glycan
envelop
glycoprotein
ha
given
exhibit
broad
spectrum
antiinfluenza
activ
well
potent
antihiv
activ
protein
would
promis
candid
entri
inhibitor
prophylact
antivir
therapi
